SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020822
Filing Date
2018-11-14
Accepted
2018-11-14 16:11:45
Documents
79
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20180930_10q.htm 10-Q 1351750
2 EXHIBIT 31.1 ex_128343.htm EX-31.1 8620
3 EXHIBIT 32.1 ex_128344.htm EX-32.1 4385
  Complete submission text file 0001437749-18-020822.txt   8228169

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nby-20180930.xml EX-101.INS 1955334
5 XBRL TAXONOMY EXTENSION SCHEMA nby-20180930.xsd EX-101.SCH 88807
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20180930_cal.xml EX-101.CAL 41066
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20180930_def.xml EX-101.DEF 533222
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20180930_lab.xml EX-101.LAB 458445
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20180930_pre.xml EX-101.PRE 563593
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 181183831
SIC: 2834 Pharmaceutical Preparations